<DOC>
	<DOC>NCT02331303</DOC>
	<brief_summary>The objective of this study is to evaluate the extent of potential off-label use of Xofigo in Sweden.</brief_summary>
	<brief_title>A Drug Utilization Study of Radium-223 in Sweden</brief_title>
	<detailed_description />
	<mesh_term>Radium Ra 223 dichloride</mesh_term>
	<criteria>Patients receiving Xofigo with data recorded at nuclear medicine centers in Sweden between 01 July 2014 and 30 June 2016 will be included in the study Patients receiving Xofigo in a clinical trial will not be included in this study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>